79141004 - ALBIX

Information

  • Trademark
  • 79141004
  • Serial Number
    79141004
  • Registration Number
    4607782
  • Filing Date
    October 09, 2013
    11 years ago
  • Registration Date
    September 23, 2014
    10 years ago
  • Transaction Date
    May 17, 2024
    9 months ago
  • Status Date
    October 08, 2023
    a year ago
  • Published for Opposition Date
    July 08, 2014
    10 years ago
  • Location Date
    February 28, 2016
    8 years ago
  • Status Code
    404
  • Current Location
    POST REGISTRATION
    Employee Name
    MAKHDOOM, SAIMA
  • Attorney Docket Number
    10249-134
    Law Office Assigned Location Code
    L10
  • Owners
Mark Drawing Code
4
Mark Identification
ALBIX
Case File Statements
  • B00001: Line 33, "in the field of development of medicines and pharmaceutical products" should be inserted after "cells" in class 42.
  • GS0051: Pharmaceutical products and substances; reagents * for pharmaceutical and medical use * ; diagnostic reagents * for medical use * ; proteins * for pharmaceutical and medical use * ; albumin * for pharmaceutical and medical use * ; recombinant albumin * for pharmaceutical and medical use * ; diagnostic imaging agents
  • B00002: In the Statement, Page 1, lines 5 - 11, "Chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, namely, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, namely, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, namely, proteins for industrial use; " should be deleted, and, In the Statement, Page 1, lines 15-17, "; chemical substances for use in tissue culture, namely, cell growth media for growing animal cells, stem cells and cell therapy preparations" should be deleted, and, In the Statement, Page 1, line 19, after reagents, "for pharmaceutical and medical use" should be inserted, and, In the Statement, Page 1, line 20 after REAGENTS, "for medical use" should be inserted, and, In the Statement, Page 1, line 20, after PROTEINS, "for pharmaceutical and medical use" should be inserted, and, In the Statement, Page 1, line 20, after ALBUMIN, "for pharmaceutical and medical use" should be inserted, and, In the Statement, Page 1, line 20, after, RECOMBINANT ALBUMIN, "for pharmaceutical and medical use" should be inserted, and, In the Statement, Page 2, line 1, after ALL RELATING TO, "the use of albumin in" should be inserted.
  • GS0011: [ Chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, namely, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, namely, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, namely, proteins for industrial use; ] albumin for use in the manufacture of pharmaceuticals, vaccines, medical substances and cell therapy preparations; chemical substances for use in diagnostic kits, namely, albumin blocking agents used to bind to test kit surfaces to prevent non-specific binding of test substances to the surface [ ; chemical substances for use in tissue culture, namely, cell growth media for growing animal cells, stem cells and cell therapy preparations ]
  • GS0421: Scientific and technological research and development services for new products and uses in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; consultancy services regarding product research and product development in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cell research; advisory services with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; providing expert analysis with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cells * in the field of development of medicines and pharmaceutical products *; and scientific development and analysis in the fields of pharmaceuticals, vaccines, and drug discoveries; all relating to * the use of albumin in * science, biotechnology, biochemistry, biology, medicine and pharmaceuticals
Case File Event Statements
  • 1/2/2014 - 11 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 1/8/2014 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/14/2014 - 11 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/25/2014 - 11 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/1/2014 - 11 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/3/2014 - 11 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/22/2014 - 11 years ago
    11 - REFUSAL PROCESSED BY IB Type: RFNT
  • 5/26/2014 - 10 years ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/31/2014 - 11 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/3/2014 - 11 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/19/2014 - 11 years ago
    9 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/19/2014 - 11 years ago
    10 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/26/2014 - 10 years ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/26/2014 - 10 years ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/5/2014 - 10 years ago
    18 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 6/18/2014 - 10 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/2/2014 - 10 years ago
    21 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/27/2014 - 10 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 5/27/2014 - 10 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/27/2014 - 10 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/2/2014 - 10 years ago
    20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 7/8/2014 - 10 years ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/8/2014 - 10 years ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/23/2014 - 10 years ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/23/2014 - 10 years ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 2/27/2015 - 9 years ago
    31 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 7/22/2014 - 10 years ago
    24 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 10/30/2014 - 10 years ago
    26 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 11/19/2014 - 10 years ago
    27 - LIMITATION FROM THE IB EXAMINED AND ENTERED Type: LIME
  • 11/19/2014 - 10 years ago
    28 - ASSIGNED TO PARALEGAL Type: PLGL
  • 11/19/2014 - 10 years ago
    29 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 2/28/2016 - 8 years ago
    41 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 2/27/2015 - 9 years ago
    32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 3/20/2015 - 9 years ago
    33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 7/20/2015 - 9 years ago
    34 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 8/20/2015 - 9 years ago
    35 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA
  • 10/22/2015 - 9 years ago
    36 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/22/2015 - 9 years ago
    37 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/19/2016 - 9 years ago
    38 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 2/24/2016 - 8 years ago
    39 - LIMITATION FROM THE IB EXAMINED AND ENTERED Type: LIME
  • 2/26/2016 - 8 years ago
    40 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 10/28/2016 - 8 years ago
    43 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 9/23/2019 - 5 years ago
    50 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 4/27/2016 - 8 years ago
    42 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/9/2016 - 8 years ago
    44 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA
  • 7/13/2017 - 7 years ago
    45 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 2/1/2018 - 7 years ago
    46 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 10/11/2018 - 6 years ago
    47 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD
  • 1/24/2019 - 6 years ago
    48 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/14/2019 - 5 years ago
    49 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 1/23/2020 - 5 years ago
    51 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 4/9/2021 - 3 years ago
    52 - CANCELLED SECTION 71 Type: C71T
  • 7/4/2022 - 2 years ago
    57 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 4/23/2021 - 3 years ago
    53 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 12/9/2021 - 3 years ago
    54 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 4/22/2022 - 2 years ago
    55 - INVALIDATION PROCESSED Type: INPC
  • 4/22/2022 - 2 years ago
    56 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS
  • 1/29/2023 - 2 years ago
    58 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/6/2024 - 9 months ago
    60 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 5/6/2024 - 9 months ago
    61 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Type: DENA
  • 5/6/2024 - 9 months ago
    62 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Type: DENC
  • 4/2/2023 - a year ago
    59 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP